Anthony P. Cahn
Gunnels Wood Road
Stevenage, ENG, United Kingdom
Stevenage, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria.
Journal: Science translational medicine
Published: June 10, 2026
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.
Journal: British journal of clinical pharmacology
Published: October 04, 2024
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.
Journal: British journal of clinical pharmacology
Published: October 04, 2024
Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open-label study.
Journal: British journal of clinical pharmacology
Published: November 11, 2022
Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc study.
Journal: British journal of clinical pharmacology
Published: November 11, 2022
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Journal: Pulmonary pharmacology & therapeutics
Published: August 09, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Journal: The European respiratory journal
Published: July 02, 2021
Mass spectrometry detection of inhaled drug in distal fibrotic lung.
Journal: Respiratory research
Published: May 14, 2021
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.
Journal: Pulmonary circulation
Published: May 05, 2021
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study.
Journal: Pulmonary therapy
Published: April 15, 2021
Last Updated: 09/26/2026